Cyclacel Pharmaceuticals, Inc. Underwriting Agreements
9 Contracts & Agreements
- Underwriting Agreement, dated March 12, 2021, by and between Cyclacel Pharmaceuticals, Inc. and Oppenheimer & Co. Inc (Filed With SEC on March 15, 2021)
- 2,164,000 SHARES ofCommon Stock, 8,872 SHARES OFSERIES A CONVERTIBLE PREFERRED STOCK (CONVERTIBLEINTO 4,436,000 SHARES OF COMMON STOCK) AND 6,600,000Warrants (exercisable for... (Filed With SEC on July 21, 2017)
- _________ SHARES ofCommon Stock, _______ SHARES OFSERIES A CONVERTIBLE PREFERRED STOCK (CONVERTIBLEINTO ____ SHARES OF COMMON STOCK) AND __________Warrants (exercisable for ____... (Filed With SEC on July 17, 2017)
- _________ SHARES ofCommon Stock, _______ SHARES OFSERIES A CONVERTIBLE PREFERRED STOCK (CONVERTIBLEINTO ____ SHARES OF COMMON STOCK) AND __________Warrants (exercisable for ____... (Filed With SEC on June 30, 2017)
- 2,857,143 Shares CYCLACEL PHARMACEUTICALS INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on April 4, 2014)
- CYCLACEL PHARMACEUTICALS, INC. (a Delaware corporation) 6,666,667 Shares UNDERWRITING AGREEMENT (Filed With SEC on May 16, 2013)
- CYCLACEL PHARMACEUTICALS, INC. (a Delaware corporation) 7,617,646 Units UNDERWRITING AGREEMENT (Filed With SEC on July 1, 2011)
- XCYTE THERAPIES, INC. Shares Common Stock ($0.001 par value per Share) UNDERWRITING AGREEMENT (Filed With SEC on February 17, 2004)
- XCYTE THERAPIES, INC. Shares Common Stock ($0.001 par value per Share) UNDERWRITING AGREEMENT (Filed With SEC on October 10, 2003)